LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.975del
PTEN
· NP_000305.3:p.(Asp326ThrfsTer18)
· NM_000314.8
GRCh37: chr10:89720822 CT>C
·
GRCh38: chr10:87961065 CT>C
Gene:
PTEN
Transcript:
NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Asp326ThrfsTer18)
gnomAD AF
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 Very Strong: exon 8 frameshift p.D326 is 5' of the PTEN NMD threshold.
2
PM2 Supporting: the variant is absent from gnomAD v2.1 and v4.1.
Final determination:
Under Rule20 of the ClinGen PTEN Expert Panel Version 3.2 framework, one Pathogenic Very Strong criterion plus one Pathogenic Supporting criterion yields Likely Pathogenic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met, very strong: exon 8 frameshift p.D326 is 49 amino-acid positions 5' of the p.D375 NMD threshold in NM_000314.8. |
cspec
vcep_pvs1_decisiontree_pten
pvs1_variant_assessment
|
| PS1 | N/A | Not applicable: NM_000314.8:c.975del is a frameshift, p.(Asp326ThrfsTer18), rather than the missense or splicing change required by the PTEN PS1 rule. |
cspec
|
| PS2 | Not assessed | Not assessed: no documented proband, parental maternity/paternity confirmation, family-history status, or proven/assumed de novo observation is available. |
cspec
|
| PS3 | Not assessed | Not assessed: mmc2 Table S2 has no c.975del or p.D326Tfs*18 functional-assay row meeting the VCEP's required High_conf and Cum_score evidence. |
cspec
vcep_mmc2
PMID:29706350
|
| PS4 | Not assessed | Not assessed: no variant-specific affected-versus-control counts, frequency comparison, odds ratio, confidence interval, or PTEN VCEP specificity score is available. |
cspec
PMID:35924163
|
| PM1 | Not met | Not met: Residue 326 is outside the PTEN PM1 catalytic motifs 90–94, 123–130, and 166–168, and the VCEP names no usable somatic-hotspot source or route. |
cspec
hotspots
|
| PM2 | Met | Met at supporting strength: the variant is absent from gnomAD v2.1 and v4.1, below the VCEP PM2 threshold of <0.00001 (0.001%). |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP explicitly excludes PM3 for PTEN. |
cspec
|
| PM4 | N/A | Not applicable: c.975del is a frameshift, while the PTEN PM4 rule names only in-frame length changes and stop-loss variants. |
cspec
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: The variant is a frameshift, whereas PTEN PM5 requires a missense change at a residue with a previously observed pathogenic or likely pathogenic missense change. |
cspec
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no assumed de novo observation with disease status, family-history status, and parental maternity/paternity information is documented. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, segregation results, or countable meioses are documented for this variant. |
cspec
|
| PP2 | N/A | Not applicable: NM_000314.8:c.975del is a frameshift, not the missense variant required by the PTEN PP2 rule. |
cspec
|
| PP3 | N/A | Not applicable: c.975del is a coding frameshift, while the PTEN PP3 rule covers only splicing and missense variants. |
cspec
|
| PP4 | N/A | Not applicable: the ClinGen PTEN VCEP explicitly marks PP4 as Not Applicable. |
cspec
|
| PP5 | N/A | Not applicable: the ClinGen PTEN VCEP explicitly marks PP5 as Not Applicable. |
cspec
|
| BA1 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, below the VCEP BA1 threshold of >0.00056 (0.056%). |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than within the VCEP BS1 range of 0.0000043–0.00056. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports no variant observations, so no confirmed homozygous healthy or PHTS-unaffected individual can be evaluated. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: mmc2 Table S2 has no p.D326Tfs*18 functional result showing high-confidence phosphatase activity >0 for the VCEP's BS3 path. |
cspec
vcep_mmc2
PMID:29706350
|
| BS4 | Not assessed | Not assessed: no affected relatives lacking the variant and no family count for lack of segregation are documented. |
cspec
|
| BP1 | N/A | Not applicable: The PTEN VCEP explicitly designates BP1 as Not Applicable. |
cspec
|
| BP2 | Not assessed | Not assessed: no documented trans, cis, or phase-unknown observation with a different pathogenic or likely pathogenic PTEN variant was available. |
cspec
|
| BP3 | N/A | Not applicable: the PTEN VCEP CSPEC entry explicitly designates BP3 as Not Applicable. |
cspec
|
| BP4 | N/A | Not applicable: c.975del is a truncating frameshift, and BP4 does not apply to frameshift variants under the PTEN VCEP rule. |
cspec
|
| BP5 | Not assessed | Not assessed: no highly penetrant alternate molecular diagnosis and no documented personal or family history excluding overlap with PTEN are available. |
cspec
|
| BP6 | N/A | Not applicable: the ClinGen PTEN VCEP explicitly marks BP6 as Not Applicable. |
cspec
|
| BP7 | N/A | Not applicable: c.975del is a coding frameshift, whereas PTEN BP7 is limited to synonymous or intronic variants at or beyond +7/-21. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.